
Potential Repurposing of Favipiravir in COVID-19 Outbreak Based on Current Evidence
To assess suitability of Favipravir for repurposing in COVID-19, we conducted a mini-review of clinical trials using Favipiravir as an investigational drug for various indications in all 18 primary clinical trial registries in the WHO Registry Network and identified 19 such trials.